(2006)
Transcriptional profiling of Candida albicans in human blood.
Microbe / ASM News 1,
76-80.
(Review)
Publikationen
(2006)
The vesicle transport protein Vac1p is required for virulence of Candida albicans.
Microbiology 152(Pt 10),
3111-3121.
(2006)
Two factor H-related proteins from the mouse: expression analysis and functional characterization.
Immunogenetics 58(11),
883-893.
(2006)
Infection-associated genes of Candida albicans.
Future Microbiol 1(2),
209-218.
(Review)
(2006)
Candida and Candidosis today: where are we, and where to go? The Interdisciplinary Forum on Candidosis (IFOCAN) 2005, Göttingen (Germany), 23-25 September 2005.
FEMS Yeast Res 6(8),
1290-1294.
(Review)
(2006)
The conversion efficiency of trans-11 and trans-12 18:1 by Delta9-desaturation differs in rats.
J Nutr 136(5),
1209-1214.
(2006)
Deletion of the gliP gene of Aspergillus fumigatus results in loss of gliotoxin production but has no effect on virulence of the fungus in a low-dose mouse infection model.
Mol Microbiol 62(1),
292-302.
(2006)
Influence of absorption enhancers on the pharmacokinetic properties of non-oral beta-lactam-cefpirom using the rabbit (Chinchilla) in vivo model.
Int J Pharm 309(1-2),
67-70.
(2006)
Comparison of susceptibility and transcription profile of the new antifungal Hassallidin A with caspofungin.
Biochem Biophys Res Commun 349(2),
740-749.
(2006)
Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors.
Med Microbiol Immunol 195(2),
65-71.